Related Experiment Video
Updated: Jun 3, 2026
06:29
Wireless Telemetry Device Implantation in a Fontan Ovine Model for Continuous and Long-Term Hemodynamic Monitoring
Published on: May 2, 2025
Liver disease in the patient with Fontan circulation
Fred M Wu1, Chinweike Ukomadu, Robert D Odze
1Boston Adult Congenital Heart Service, Department of Cardiology, Children's Hospital Boston, Boston, MA 02115, USA. fred.wu@cardio.chboston.org
Congenital Heart Disease
|March 30, 2011
Summary
The Fontan procedure, a surgery for single-ventricle physiology, can lead to liver issues over time. This review examines liver disease in Fontan survivors and its impact on long-term health.
Area of Science:
- Cardiology
- Hepatology
- Pediatric Surgery
Background:
- The Fontan procedure is the standard surgical approach for complex single-ventricle congenital heart disease.
- Long-term Fontan circulation can lead to various complications, including liver dysfunction.
- Liver abnormalities and clotting cascade issues are recognized in Fontan patients but their clinical significance is not fully understood.
Purpose of the Study:
- To review current data on liver disease in the Fontan population.
- To understand the clinical significance of hepatic dysfunction in Fontan survivors.
- To identify unanswered questions regarding liver health in this cohort.
Main Methods:
- Literature review of studies on Fontan procedure outcomes.
- Analysis of data on liver abnormalities and hepatic dysfunction in Fontan patients.
- Synthesis of information on the impact of liver disease on Fontan circulation.
Main Results:
- Fontan survivors show increasing prevalence of subclinical hepatic dysfunction.
- Liver disease contributes to adverse outcomes in individuals with Fontan circulation.
- Abnormalities in the clotting cascade are frequently observed.
Conclusions:
- Liver disease is an increasingly recognized complication in the aging Fontan population.
- Further research is needed to clarify the long-term consequences of hepatic dysfunction in Fontan survivors.
- Understanding and managing liver health is crucial for improving outcomes in Fontan patients.
Related Concept Videos
01:22Portal Hypertension
Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...